NCT04209699

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

An Open-label 3×3 Cross-over Study to Compare Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of Single Doses of BMS-986165 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Bristol-Myers Squibb · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to evaluate the effects of food and pH on the relative bioavailability (BA) of the tablet formulation of BMS-986165 in healthy volunteers

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	BMS-986165	Single dose
DRUG	Famotidine	Single dose

Timeline

• Start date: 2019-12-27
• Primary completion: 2020-02-04
• Completion: 2020-02-11
• First posted: 2019-12-24
• Last updated: 2020-04-21

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study